Mehra, M.R., Naka, Y., Uriel, N., Goldstein, D.J., Cleveland, J.C., Colombo, P.C., …, Salerno, C., for the MOMENTUM 3 Investigators. (2017). A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med, 376(5), 440-50. https://www.nejm.org/doi/10.1056/NEJMoa1610426.
In this primary six-month analysis of the MOMENTUM 3 trial, the HeartMate 3 LVAS demonstrates:
Uriel, N., Colombo, P.C., Cleveland, J.C., Long, J.W., Salerno, C., Goldstein, D.J., … Mehra, M.R. (2017). Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation, 135(21), 2003-12. https://doi.org/10.1161/CIRCULATIONAHA.117.028303
In this secondary analysis of the MOMENTUM 3 trial, the HeartMate 3 LVAS demonstrated higher freedom from an aggregate of hemocompatibility-related adverse events at six months in comparison to HeartMate II LVAS.
Goldstein, D.J., Mehra, M.R., Naka, Y., Salerno, C., Uriel, N., Dean, D., … Cleveland, J. for the MOMENTUM 3 Investigators. (2018). Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial, J Heart Lung Transplant, 37 (1), 7-14. https://doi.org/10.1016/j.healun.2017.11.001
This analysis of the MOMENTUM 3 trial demonstrates the following:
Cowger, J.A., Naka, Y., Aaronson, K.D., Horstmanshof, D., Gulati, S., Rinde-Hoffman, D., … Jorde, U.P. on behalf of the MOMENTUM 3 Investigators. (2018). Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. J Heart Lung Transplant, 37 (1), 15-24. https://doi.org/10.1016/j.healun.2017.10.019
The analysis of this study on health-related quality of life (HR-QOL) and functional capacity shows that:
MAT-2006847 v3.0
STAY CONNECTED